Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
about
Inflammation and its role in age-related macular degenerationAutoimmune retinopathyRetinal ganglion cell loss is accompanied by antibody depositions and increased levels of microglia after immunization with retinal antigensAutoimmune retinopathy.Paraneoplastic neurological complications of breast cancer.Circulating Autoantibodies in Age-Related Macular Degeneration Recognize Human Macular Tissue Antigens Implicated in Autophagy, Immunomodulation, and Protection from Oxidative Stress and ApoptosisHigh-resolution contrast-enhanced optical coherence tomography in mice retinaeSystemic frequencies of T helper 1 and T helper 17 cells in patients with age-related macular degeneration: A case-control study.Retinal ultrastructure of murine models of dry age-related macular degeneration (AMD).The alternative pathway is required, but not alone sufficient, for retinal pathology in mouse laser-induced choroidal neovascularization.Efficacy of rituximab in non-paraneoplastic autoimmune retinopathy.γδ T cells as a major source of IL-17 production during age-dependent RPE degeneration.Prevalence of anti-retinal autoantibodies in different stages of Age-related macular degeneration.A randomized pilot study of systemic immunosuppression in the treatment of age-related macular degeneration with choroidal neovascularizationGenomic regulation of senescence and innate immunity signaling in the retinal pigment epithelium.Inflammatory Mechanisms of Age-related Macular Degeneration.The association between neovascular age-related macular degeneration and regulatory T cells in peripheral blood.Connecting the innate and adaptive immune responses in mouse choroidal neovascularization via the anaphylatoxin C5a and γδT-cells.Systems-level analysis of age-related macular degeneration reveals global biomarkers and phenotype-specific functional networks.Immunological protein expression profile in Ccl2/Cx3cr1 deficient mice with lesions similar to age-related macular degeneration.Age-related macular degeneration and the immune response: implications for therapy.The role of the immune response in age-related macular degenerationReview of genetics in age related macular degeneration.Common variation in the SERPING1 gene is not associated with age-related macular degeneration in two independent groups of subjects.The enigma of autoimmune retinopathy.Molecular pathology of age-related macular degenerationFcγ receptor upregulation is associated with immune complex inflammation in the mouse retina and early age-related macular degeneration.Immunology of age-related macular degenerationInflammation and age-related macular degeneration (AMD).Autoimmunity and age-related macular degeneration: a review of the literature.The immunological basis of degenerative diseases of the eye.Potential Sources and Roles of Adaptive Immunity in Age-Related Macular Degeneration: Shall We Rename AMD into Autoimmune Macular Disease?Cell-based therapeutic strategies for replacement and preservation in retinal degenerative diseases.Can innate and autoimmune reactivity forecast early and advance stages of age-related macular degeneration?The impact of oxidative stress and inflammation on RPE degeneration in non-neovascular AMD.Age-related macular degeneration in patients with uveitis.Antiretinal antibody- proven autoimmune retinopathy.Antiretinal antibodies in central serous chorioretinopathy: prevalence and clinical implications.Prevalence of anti-retinal antibodies in epiretinal membranes and macular holes.Serum anti-endothelial cell antibodies in patients with age-related macular degeneration treated with intravitreal bevacizumab.
P2860
Q26768520-4D5077FC-0DA3-4FB5-9498-C1F1794D400CQ27027058-97776D8E-CA18-424D-922D-08C266630EEDQ27334415-BCAE609D-B362-4AE8-A351-53C56CE1A8ACQ27694736-E81F4ABA-79E1-4F32-977C-93B9DE474C1AQ28077708-2B1F6B12-5DEA-43D4-A15B-1A8080CE5FE2Q28551885-276F6A56-E9C1-4F8F-B1A3-7F805DC27A0DQ30766004-1B10B1D9-3B97-40D4-9D3A-81E77C4EE2FCQ33677692-A3707995-DE48-431E-910E-6CEF997498A3Q33787737-C755B41F-EDFA-4C49-BA7F-34D7C55D1823Q33800561-32612010-E23E-41C5-BB86-9CBD6957EE05Q33909097-BA1F539F-05A0-4143-B4BF-25EF6996C3F9Q34371913-333166E6-803E-42BC-BCC4-14C166BC4087Q34728024-AF1F6B61-9608-4B65-842C-3CA1423B086BQ35215452-3DF33AB6-EEDB-439A-81D7-654B7362E666Q35668596-E21F68B5-F802-41E6-AA2E-076DD3D82F4AQ35755942-8C0DF8AF-E949-4C5E-8892-178B7EA5047CQ35799403-F30C0B15-336E-4188-B416-2A02FECAE3C8Q35974464-74F7509E-ABCD-4ACF-BBD7-673C2473054CQ36023209-057BE7D2-2604-4868-9039-BD3663DA8102Q36644485-6018ADC0-3576-4357-92B9-86BA7345D707Q36909934-03D24F27-1C32-4BA4-A815-98DE52E76B14Q36914129-4A850C5D-106B-40B8-97B2-7A536C779E4DQ37039797-97BC16A7-F26D-4127-A913-BADCA1B74D33Q37069747-C52C424D-02B1-4E4C-BA14-EEA30BBF934CQ37088449-2E3D387E-ACBE-41C4-98C2-6AC780ECEBECQ37273740-A1A509AE-1F7C-4EE7-8F9C-774CE8A052DAQ37476633-F3BFAB13-B30C-4A61-8FA1-A84756397FCDQ37614752-CABE8686-9D77-4C71-A1FC-358BE7503D82Q37879176-869F0DDB-5D0A-407E-BACC-969309DD4E9EQ37940594-C120C79F-6A1A-4DFA-9E0E-7B8AD50AB7E3Q38077553-26042AB2-988C-4CAB-9354-72B12716BB1CQ38216031-20803FEF-8992-4FAE-A846-F4E6EAD744ABQ38767261-AFC6ECF1-4BEA-4F76-A8F9-56A73E1327B2Q39110045-72AEF1F5-B528-47DE-A9A4-681D471C3D20Q39197341-AE69824D-D3EB-4334-8556-2EB99979E543Q39786855-BA41F4E4-1E53-43DF-AD2C-A433F099C41FQ41480080-22866E36-4029-4E84-B97C-3EEDCF49D709Q48230269-A09AEB00-E6D3-436A-9E5D-7853D322EFFAQ48308322-2A322622-0048-44D7-BD01-A5CA1A767E9CQ51689746-9F5E4AC4-38B6-4229-9B4B-BE3ED840889C
P2860
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
description
2005 nî lūn-bûn
@nan
2005 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2005 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2005年の論文
@ja
2005年論文
@yue
2005年論文
@zh-hant
2005年論文
@zh-hk
2005年論文
@zh-mo
2005年論文
@zh-tw
2005年论文
@wuu
name
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@ast
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@en
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@nl
type
label
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@ast
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@en
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@nl
prefLabel
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@ast
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@en
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@nl
P2093
P2860
P3181
P1433
P1476
Circulating anti-retinal antibodies as immune markers in age-related macular degeneration
@en
P2093
Alan C Bird
Alex K Nugent
Andrew Webster
Kai-Yin Chau
Kanchan Ramchand
Masahara Ohbayashi
Masako Toda
Nishal Patel
Santa Jeremy Ono
P2860
P304
P3181
P356
10.1111/J.1365-2567.2005.02173.X
P407
P577
2005-07-01T00:00:00Z